Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125870851 | 12587085 | 1 | I | 20151029 | 20151210 | 20160725 | 20160725 | PER | US-PFIZER INC-3114338 | PFIZER | 62.00 | YR | M | Y | 118.80000 | KG | 20160725 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125870851 | 12587085 | 1 | PS | VANCOMYCIN HCL | VANCOMYCIN HYDROCHLORIDE | 1 | UNK | Y | UNK | 62911 | |||||||||
| 125870851 | 12587085 | 2 | SS | INVESTIGATIONAL DRUG | INVESTIGATIONAL PRODUCT | 1 | Subcutaneous | FREQ: 1 WEEK; INTERVAL: 2 | UNK | 0 | |||||||||
| 125870851 | 12587085 | 3 | SS | PLACEBO | UNSPECIFIED INGREDIENT | 1 | Subcutaneous | FREQ: 1 WEEK; INTERVAL: 2 | UNK | 0 | |||||||||
| 125870851 | 12587085 | 4 | C | NOVOLIN | INSULIN HUMAN | 1 | Subcutaneous | 16 IU, FREQ: 1 DAY; INTERVAL: 1 | 0 | 16 | IU | ||||||||
| 125870851 | 12587085 | 5 | C | NOVOLIN | INSULIN HUMAN | 1 | Subcutaneous | 18 IU, FREQ: 1 DAY; INTERVAL: 1 | 0 | 18 | IU | ||||||||
| 125870851 | 12587085 | 6 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | Oral | 81 MG, FREQ: 1 DAY; INTERVAL: 1 | 0 | 81 | MG | ||||||||
| 125870851 | 12587085 | 7 | C | BENAZEPRIL | BENAZEPRIL HYDROCHLORIDE | 1 | Oral | 10 MG, FREQ: 1 DAY; INTERVAL: 1 | 0 | 10 | MG | ||||||||
| 125870851 | 12587085 | 8 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 25 MG, FREQ: 2 DAY; INTERVAL: 1 | 0 | 25 | MG | ||||||||
| 125870851 | 12587085 | 9 | C | DICLOFENAC | DICLOFENAC | 1 | Topical | 1 %, FREQ: AS NECESSARY | 0 | 1 | PCT | GEL | |||||||
| 125870851 | 12587085 | 10 | C | ERYTHROMYCIN. | ERYTHROMYCIN | 1 | DOSE: 1 APP; ROUTE OF ADMINISTRATION: OINT, FREQ: AS NECESSARY | 0 | OINTMENT | ||||||||||
| 125870851 | 12587085 | 11 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 40 MG, FREQ: 1 DAY; INTERVAL: 1 | 0 | 40 | MG | ||||||||
| 125870851 | 12587085 | 12 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 25 MG, FREQ: AS NECESSARY | 0 | 25 | MG | ||||||||
| 125870851 | 12587085 | 13 | C | WARFARIN | WARFARIN | 1 | Oral | 5 MG, X 1 WEEK | 0 | 5 | MG | ||||||||
| 125870851 | 12587085 | 14 | C | WARFARIN | WARFARIN | 1 | Oral | 7.5 MG, X 6 WEEK | 0 | 7.5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125870851 | 12587085 | 1 | Product used for unknown indication |
| 125870851 | 12587085 | 2 | Cardiovascular disorder |
| 125870851 | 12587085 | 3 | Cardiovascular disorder |
| 125870851 | 12587085 | 4 | Diabetes mellitus |
| 125870851 | 12587085 | 6 | Atrial fibrillation |
| 125870851 | 12587085 | 7 | Hypertension |
| 125870851 | 12587085 | 8 | Cardiac failure congestive |
| 125870851 | 12587085 | 9 | Osteoarthritis |
| 125870851 | 12587085 | 10 | Blepharitis |
| 125870851 | 12587085 | 11 | Hyperlipidaemia |
| 125870851 | 12587085 | 12 | Cardiac failure congestive |
| 125870851 | 12587085 | 13 | Atrial fibrillation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125870851 | 12587085 | HO |
| 125870851 | 12587085 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125870851 | 12587085 | Acute kidney injury | |
| 125870851 | 12587085 | Osteomyelitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125870851 | 12587085 | 1 | 20151101 | 20151101 | 0 | |
| 125870851 | 12587085 | 2 | 20141212 | 20150306 | 0 | |
| 125870851 | 12587085 | 3 | 20141212 | 20150306 | 0 | |
| 125870851 | 12587085 | 4 | 20110101 | 0 | ||
| 125870851 | 12587085 | 5 | 20110101 | 0 | ||
| 125870851 | 12587085 | 6 | 20040101 | 0 | ||
| 125870851 | 12587085 | 7 | 20040101 | 20151128 | 0 | |
| 125870851 | 12587085 | 8 | 20110101 | 0 | ||
| 125870851 | 12587085 | 9 | 20110101 | 0 | ||
| 125870851 | 12587085 | 10 | 20110101 | 0 | ||
| 125870851 | 12587085 | 11 | 20080101 | 0 | ||
| 125870851 | 12587085 | 12 | 20110101 | 20151128 | 0 | |
| 125870851 | 12587085 | 13 | 19950101 | 0 | ||
| 125870851 | 12587085 | 14 | 19950101 | 0 |